CLSA Downgrades Telix Pharmaceuticals Ltd (TLX:AU) to Outperform (2)

February 28, 2021 10:05 AM EST
Get Alerts AU Hot Sheet
Price: $22.06 -0.81%

Rating Summary:
    7 Buy, 4 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 17 | Down: 14 | New: 42
Trade Now! 
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

CLSA analyst Silvia Luo downgraded Telix Pharmaceuticals Ltd (TLX:AU) from Buy (1) to Outperform (2) with a price target of AUD4.30 (from AUD4.30).

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Downgrades, Intl Ratings